CLINICAL_TRIALS
trial_result
· 2024-07-08
Clinical Trial Update: A Study to Investigate Efficacy and Safety of VTAMA (Tapinarof) Cream, 1% in Intertriginous Plaque Psoriasis [Phase 4]
Summary
Phase 4 study assessing the efficacy and safety of VTAMA (tapinarof) 1% cream for intertriginous plaque psoriasis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Organon and Co | Conditions: Psoriasis | Phase 4 | Status: COMPLETED | Results posted: 2024-07-08